Stock Screener App

Frei -

Installieren

7.40

5.25% -0.41

after-market

Handel nachbörslich: 7.40

Cullinan Therapeutics Inc (CGEM)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Finanzdaten der Cullinan Therapeutics Inc-Aktie (CGEM)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-06-30	2025-03-31	2024-09-30	2024-06-30	2024-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	-	-	-	-	-
Operating Expenses	37.82% 75.80	55.00	48.85	50.03	42.99
Operating Income/Loss	37.82% -75.80	-55.00	-48.85	-50.03	-42.99
Income/Loss From Continuing Operations Before Tax	44.44% -70.06	-48.50	-40.56	-42.03	-37.34
Income/Loss From Continuing Operations After Tax	44.44% -70.06	-48.50	-40.56	-42.03	-37.34
Net Income/Loss	44.44% -70.06	-48.50	-40.56	-42.03	-37.34
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-0.192
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

RPRX

$37.84

1.45%

GMAB

$28.76

0.17%

INCY

$102.92

1.33%

BNTX

$104.83

0.84%

ONC

$309.19

0.86%

INSM

$182.77

1.86%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters